Caterna Overview

  • Founded
  • 2010

  • Status
  • Private

  • Employees
  • 8

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Caterna General Information


Operator of an online therapy platform designed to provide a supplement to occlusion therapy for children with amblyopia or lazy eye. The company's platform offers web-based exercises for the treatment of neurological defect vision which are combined with online games for attention-grabbing in the screen foreground, enabling patients to stimulate the brain to re-establish the connection between brain and eye.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Clinics/Outpatient Services
Primary Office
  • David-Gilly-Strasse 1
  • 14469 Potsdam
  • Germany
+49 0331 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caterna Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 24-Jul-2017 Completed Generating Revenue
5. Early Stage VC (Series A) 01-May-2014 Completed Generating Revenue
4. Grant 04-Jun-2013 0000 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue
2. Bankruptcy: Admin/Reorg 01-Jan-2012 Completed Bankruptcy: Admin/Reorg
1. Early Stage VC 14-Jan-2011 $855K $855K Completed Startup
To view Caterna’s complete valuation and funding history, request access »

Caterna Patents

Caterna Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9597253-B2 Method and apparatus for the treatment of amblyopia Active 20-Mar-2015 00000000 0
US-20160271001-A1 Method and apparatus for the treatment of amblyopia Granted 20-Mar-2015 00000000
DE-202014001153-U1 Digital occlusion diary with reminder function to support ocular patch treatment for amblyopia Expired - Lifetime 07-Feb-2014 00000000
EP-2782493-A1 Method and device improving visual performance Pending 23-Nov-2011 00000000
US-20150146167-A1 Method and device for improving visual performance Abandoned 23-Nov-2011 A61H5/00 0
To view Caterna’s complete patent history, request access »

Caterna Executive Team (5)

Name Title Board Seat Contact Info
Jana Frömke Chief Executive Officer & Managing Director
Nicolaus Widera Co-Founder & Managing Director
Sascha Seewald Co-Founder & Advisor
Johannes Rösler Co-Founder
You’re viewing 4 of 5 executive team members. Get the full list »

Caterna Board Members (2)

Name Representing Role Since
Klaus Stöckemann Ph.D Peppermint Venture Partners Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Caterna Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Caterna Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brandenburg Kapital Venture Capital Minority 000 0000 000000 0
Investitionsbank des Landes Brandenburg Investment Bank Minority 000 0000 000000 0
Peppermint Venture Partners Venture Capital Minority 000 0000 000000 0
Flying Health Accelerator/Incubator 000 0000 000000 0
To view Caterna’s complete investors history, request access »